Precision Cancer Diagnostic Tests Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Precision Cancer Diagnostic Tests involves the imaging, in- vitro diagnostic testing and procedures which confirm and detect cancer progression and malignancies in patient's tissue sample. These precision cancer diagnostic tests also play a key part in cancer staging, making them extremely accurate and reliable. Precision cancer diagnostic tests are also used to track and evaluate a patient's ongoing cancer treatment, including whether or not the disease is responding to treatment. The rising prevalence of cancers, increasing demand for precision diagnostics for early detection of disease are expected to boost market growth during the forecast period.
MARKET SCOPE
The "Global Precision Cancer Diagnostic Tests Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the precision cancer diagnostic tests market with detailed market segmentation by product type and end user. The report provides key statistics on the market status of the leading precision cancer diagnostic tests market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product type the market is segmented as, imaging, molecular, tumor marker immunoassays and POC colon cancer tests.
- Based on end user the market is segmented as, hospital, clinic and others.
MARKET DYNAMICS
Drivers:
- Increasing prevalences of cancers and malignancies across the globe.
- Rising demand for precision diagnostics for early detection of disease is expected to spur the market growth.
- Technological advancements in cancer diagnostics for accurate results is also expected to create significant growth opportunities for the market growth.
Restraints:
- Whereas, high cost of diagnostic imaging tests and presence of stringent regulatory framework are expected to restrain market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The precision cancer diagnostic tests market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the precision cancer diagnostic tests market in these regions.
IMPACT OF COVID-19 ON PRECISION CANCER DIAGNOSTIC TESTS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The precision cancer diagnostic tests market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the precision cancer diagnostic tests market in these regions.
IMPACT OF COVID-19 ON PRECISION CANCER DIAGNOSTIC TESTS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the precision cancer diagnostic tests market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from precision cancer diagnostic tests market are anticipated to lucrative growth opportunities in the future with the rising demand for precision cancer diagnostic tests in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the precision cancer diagnostic tests market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott
- Agilent Technologies Inc.
- BD
- Bio-Rad Laboratories Inc.
- Biocartis
- bioMerieux SA
- MYRIAD ONCOLOGY
- Hologic Inc.
- QIAGEN
- Thermo Fisher Scientific
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Precision Cancer Diagnostic Tests Market - By Product Type
1.3.2 Precision Cancer Diagnostic Tests Market - By End User
1.3.3 Precision Cancer Diagnostic Tests Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PRECISION CANCER DIAGNOSTIC TESTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. PRECISION CANCER DIAGNOSTIC TESTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PRECISION CANCER DIAGNOSTIC TESTS MARKET - GLOBAL MARKET ANALYSIS
6.1. PRECISION CANCER DIAGNOSTIC TESTS - GLOBAL MARKET OVERVIEW
6.2. PRECISION CANCER DIAGNOSTIC TESTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PRECISION CANCER DIAGNOSTIC TESTS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. IMAGING
7.3.1. Overview
7.3.2. Imaging Market Forecast and Analysis
7.4. MOLECULAR
7.4.1. Overview
7.4.2. Molecular Market Forecast and Analysis
7.5. TUMOR MARKER IMMUNOASSAYS
7.5.1. Overview
7.5.2. Tumor Marker Immunoassays Market Forecast and Analysis
7.6. POC COLON CANCER TESTS
7.6.1. Overview
7.6.2. POC Colon Cancer Tests Market Forecast and Analysis
8. PRECISION CANCER DIAGNOSTIC TESTS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. PRECISION CANCER DIAGNOSTIC TESTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Precision Cancer Diagnostic Tests Market Overview
9.1.2 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.1.3 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.1.4 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.1.5 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.1.5.1 United States Precision Cancer Diagnostic Tests Market
9.1.5.1.1 United States Precision Cancer Diagnostic Tests Market by Product Type
9.1.5.1.2 United States Precision Cancer Diagnostic Tests Market by End User
9.1.5.2 Canada Precision Cancer Diagnostic Tests Market
9.1.5.2.1 Canada Precision Cancer Diagnostic Tests Market by Product Type
9.1.5.2.2 Canada Precision Cancer Diagnostic Tests Market by End User
9.1.5.3 Mexico Precision Cancer Diagnostic Tests Market
9.1.5.3.1 Mexico Precision Cancer Diagnostic Tests Market by Product Type
9.1.5.3.2 Mexico Precision Cancer Diagnostic Tests Market by End User
9.2. EUROPE
9.2.1 Europe Precision Cancer Diagnostic Tests Market Overview
9.2.2 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.2.3 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.2.4 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.2.5 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Precision Cancer Diagnostic Tests Market
9.2.5.1.1 Germany Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.1.2 Germany Precision Cancer Diagnostic Tests Market by End User
9.2.5.2 France Precision Cancer Diagnostic Tests Market
9.2.5.2.1 France Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.2.2 France Precision Cancer Diagnostic Tests Market by End User
9.2.5.3 Italy Precision Cancer Diagnostic Tests Market
9.2.5.3.1 Italy Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.3.2 Italy Precision Cancer Diagnostic Tests Market by End User
9.2.5.4 Spain Precision Cancer Diagnostic Tests Market
9.2.5.4.1 Spain Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.4.2 Spain Precision Cancer Diagnostic Tests Market by End User
9.2.5.5 United Kingdom Precision Cancer Diagnostic Tests Market
9.2.5.5.1 United Kingdom Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.5.2 United Kingdom Precision Cancer Diagnostic Tests Market by End User
9.2.5.6 Rest of Europe Precision Cancer Diagnostic Tests Market
9.2.5.6.1 Rest of Europe Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.6.2 Rest of Europe Precision Cancer Diagnostic Tests Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Overview
9.3.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.3.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Precision Cancer Diagnostic Tests Market
9.3.5.1.1 Australia Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.1.2 Australia Precision Cancer Diagnostic Tests Market by End User
9.3.5.2 China Precision Cancer Diagnostic Tests Market
9.3.5.2.1 China Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.2.2 China Precision Cancer Diagnostic Tests Market by End User
9.3.5.3 India Precision Cancer Diagnostic Tests Market
9.3.5.3.1 India Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.3.2 India Precision Cancer Diagnostic Tests Market by End User
9.3.5.4 Japan Precision Cancer Diagnostic Tests Market
9.3.5.4.1 Japan Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.4.2 Japan Precision Cancer Diagnostic Tests Market by End User
9.3.5.5 South Korea Precision Cancer Diagnostic Tests Market
9.3.5.5.1 South Korea Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.5.2 South Korea Precision Cancer Diagnostic Tests Market by End User
9.3.5.6 Rest of Asia-Pacific Precision Cancer Diagnostic Tests Market
9.3.5.6.1 Rest of Asia-Pacific Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Precision Cancer Diagnostic Tests Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Precision Cancer Diagnostic Tests Market Overview
9.4.2 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.4.3 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Precision Cancer Diagnostic Tests Market
9.4.5.1.1 South Africa Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.1.2 South Africa Precision Cancer Diagnostic Tests Market by End User
9.4.5.2 Saudi Arabia Precision Cancer Diagnostic Tests Market
9.4.5.2.1 Saudi Arabia Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.2.2 Saudi Arabia Precision Cancer Diagnostic Tests Market by End User
9.4.5.3 U.A.E Precision Cancer Diagnostic Tests Market
9.4.5.3.1 U.A.E Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.3.2 U.A.E Precision Cancer Diagnostic Tests Market by End User
9.4.5.4 Rest of Middle East and Africa Precision Cancer Diagnostic Tests Market
9.4.5.4.1 Rest of Middle East and Africa Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Precision Cancer Diagnostic Tests Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Precision Cancer Diagnostic Tests Market Overview
9.5.2 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.5.3 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.5.5 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Precision Cancer Diagnostic Tests Market
9.5.5.1.1 Brazil Precision Cancer Diagnostic Tests Market by Product Type
9.5.5.1.2 Brazil Precision Cancer Diagnostic Tests Market by End User
9.5.5.2 Argentina Precision Cancer Diagnostic Tests Market
9.5.5.2.1 Argentina Precision Cancer Diagnostic Tests Market by Product Type
9.5.5.2.2 Argentina Precision Cancer Diagnostic Tests Market by End User
9.5.5.3 Rest of South and Central America Precision Cancer Diagnostic Tests Market
9.5.5.3.1 Rest of South and Central America Precision Cancer Diagnostic Tests Market by Product Type
9.5.5.3.2 Rest of South and Central America Precision Cancer Diagnostic Tests Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PRECISION CANCER DIAGNOSTIC TESTS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AGILENT TECHNOLOGIES INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BD
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BIO-RAD LABORATORIES INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BIOCARTIS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIOMERIEUX SA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MYRIAD ONCOLOGY
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. HOLOGIC INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. QIAGEN
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. THERMO FISHER SCIENTIFIC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Abbott
2. Agilent Technologies Inc.
3. BD
4. Bio-Rad Laboratories Inc.
5. Biocartis
6. bioMerieux SA
7. MYRIAD ONCOLOGY
8. Hologic Inc.
9. QIAGEN
10. Thermo Fisher Scientific
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For